+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiogenesis"

From
Live Cell Imaging Market - Focused Insights 2025-2030 - Product Thumbnail Image

Live Cell Imaging Market - Focused Insights 2025-2030

  • Report
  • March 2025
  • 143 Pages
  • Global
From
From
From
Endothelial Cell Media Market - Global Forecast 2025-2030 - Product Thumbnail Image

Endothelial Cell Media Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
From
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • October 2025
  • Global
3D Cell Cultures: Technologies and Global Markets - Product Thumbnail Image

3D Cell Cultures: Technologies and Global Markets

  • Report
  • February 2024
  • 442 Pages
  • Global
From
From
Nanotechnology in Ophthalmology - Product Thumbnail Image

Nanotechnology in Ophthalmology

  • Book
  • July 2023
Loading Indicator

Angiogenesis is a process in biotechnology that involves the growth of new blood vessels from existing vessels. It is a key factor in the development of many diseases, including cancer, diabetes, and cardiovascular diseases. It is also a key factor in wound healing and tissue regeneration. Angiogenesis is a rapidly growing field of biotechnology, with many companies developing treatments and therapies to target the process. Companies are researching and developing drugs that target the growth of new blood vessels, as well as treatments that inhibit the growth of existing vessels. Additionally, companies are researching and developing gene therapies and stem cell therapies to target angiogenesis. Some companies in the angiogenesis market include Regeneron Pharmaceuticals, Novartis, AstraZeneca, and Amgen. Show Less Read more